Total Payments
$1,510
2023 Payments
$22.94
Companies
20
Transactions
60
Medicare Patients
32,525
Medicare Billing
$3.1M
Payment Breakdown by Category
Food & Beverage$1,456 (96.4%)
Education$54.28 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,456 | 58 | 96.4% |
| Education | $54.28 | 2 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $485.02 | 13 | $0 (2018) |
| Kite Pharma, Inc. | $155.53 | 9 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $128.68 | 7 | $0 (2019) |
| Dova Pharmaceuticals | $125.00 | 1 | $0 (2020) |
| Puma Biotechnology, Inc. | $119.46 | 1 | $0 (2018) |
| Incyte Corporation | $74.83 | 4 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $55.74 | 3 | $0 (2020) |
| BeiGene USA, Inc. | $54.28 | 2 | $0 (2022) |
| Sirtex Medical Inc | $43.57 | 3 | $0 (2022) |
| Secura Bio, Inc. | $39.12 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $22.94 | 1 | Tactile Systems Technology Inc ($22.94) |
| 2022 | $109.93 | 6 | BeiGene USA, Inc. ($54.28) |
| 2021 | $151.72 | 9 | Kite Pharma, Inc. ($52.68) |
| 2020 | $292.30 | 11 | Dova Pharmaceuticals ($125.00) |
| 2019 | $51.05 | 3 | Merck Sharp & Dohme Corporation ($19.91) |
| 2018 | $447.45 | 16 | Novartis Pharmaceuticals Corporation ($193.00) |
| 2017 | $434.49 | 14 | Novartis Pharmaceuticals Corporation ($292.02) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/12/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Education | In-kind items and services | $27.14 | General |
| Category: Oncology | ||||||
| 11/23/2022 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: Interventional Oncology | ||||||
| 11/16/2022 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Oncology | ||||||
| 11/08/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Education | In-kind items and services | $27.14 | General |
| Category: Oncology | ||||||
| 05/10/2022 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $18.84 | General |
| Category: Interventional Oncology | ||||||
| 03/02/2022 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $9.17 | General |
| Category: Interventional Oncology | ||||||
| 11/15/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.68 | General |
| 10/27/2021 | Secura Bio, Inc. | FARYDAK (Drug), COPIKTRA | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 10/04/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: ONCOLOGY | ||||||
| 06/30/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.16 | General |
| 06/18/2021 | Astellas Pharma US Inc | XOSPATA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2021 | Kyowa Kirin, Inc. | POTELIGEO (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: MONOCLONAL ANTIBODY | ||||||
| 05/12/2021 | Secura Bio, Inc. | FARYDAK (Drug), COPIKTRA | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 03/04/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.84 | General |
| 02/23/2021 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: BioOncology | ||||||
| 11/24/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $11.02 | General |
| 11/12/2020 | Secura Bio, Inc. | Farydak (Drug) | Food and Beverage | Cash or cash equivalent | $11.63 | General |
| Category: Oral Oncologic | ||||||
| 10/21/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $22.56 | General |
| 10/13/2020 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hematology/Oncology | ||||||
| 09/24/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $16.05 | General |
| 08/19/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.58 | General |
| 07/16/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $22.24 | General |
| 06/02/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $13.40 | General |
| 05/04/2020 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 73 | 8,858 | 97,271 | $4.0M | $733,588 |
| 2022 | 69 | 8,131 | 100,407 | $4.0M | $643,482 |
| 2021 | 72 | 8,374 | 136,044 | $5.6M | $898,524 |
| 2020 | 68 | 7,162 | 113,546 | $5.2M | $823,478 |
Total Patients
32,525
Total Services
447,268
Medicare Billing
$3.1M
Procedure Codes
282
All Medicare Procedures & Services
282 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 394 | 1,228 | $564,880 | $139,051 | 24.6% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 136 | 4,991 | $539,028 | $115,119 | 21.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 3,420 | $294,600 | $62,909 | 21.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 302 | 504 | $191,520 | $55,904 | 29.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 164 | 771 | $115,650 | $42,347 | 36.6% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 34 | 39,750 | $198,750 | $34,724 | 17.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 586 | 2,061 | $41,220 | $17,254 | 41.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 413 | 1,235 | $185,250 | $16,373 | 8.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 519 | 1,548 | $92,880 | $15,904 | 17.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 570 | 2,093 | $313,950 | $15,764 | 5.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 27 | 129 | $70,950 | $15,729 | 22.2% |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | Office | 2023 | 136 | 217 | $65,100 | $15,596 | 24.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 98 | 236 | $118,000 | $14,129 | 12.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 56 | 56 | $43,680 | $11,541 | 26.4% |
| 83550 | Iron binding capacity | Office | 2023 | 408 | 1,220 | $152,500 | $10,366 | 6.8% |
| 83735 | Magnesium level | Office | 2023 | 441 | 1,345 | $100,875 | $8,738 | 8.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 99 | $29,700 | $8,077 | 27.2% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 142 | 870 | $39,150 | $7,901 | 20.2% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 441 | 1,347 | $40,410 | $7,893 | 19.5% |
| 83540 | Iron level | Office | 2023 | 412 | 1,235 | $86,450 | $7,777 | 9.0% |
| 83521 | Measurement of immunoglobulin light chains | Office | 2023 | 115 | 374 | $26,180 | $6,330 | 24.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 125 | 487 | $92,530 | $6,207 | 6.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 246 | 419 | $31,425 | $6,168 | 19.6% |
| 84100 | Phosphate level | Office | 2023 | 441 | 1,282 | $64,100 | $5,877 | 9.2% |
| 84550 | Uric acid level, blood | Office | 2023 | 426 | 1,311 | $65,550 | $5,752 | 8.8% |
About Dr. Gerry Rubin, MD
Dr. Gerry Rubin, MD is a Hematology & Oncology healthcare provider based in Bay Shore, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982677761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerry Rubin, MD has received a total of $1,510 in payments from pharmaceutical and medical device companies, with $22.94 received in 2023. These payments were reported across 60 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,456).
As a Medicare-enrolled provider, Rubin has provided services to 32,525 Medicare beneficiaries, totaling 447,268 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 282 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Bay Shore, NY
- Active Since 02/10/2006
- Last Updated 08/06/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1982677761
Products in Payments
- TASIGNA (Drug) $159.40
- KISQALI (Drug) $140.64
- Doptelet (Drug) $125.00
- Nerlynx (Drug) $119.46
- JAKAFI (Drug) $74.83
- XARELTO (Drug) $55.74
- BRUKINSA (Drug) $54.28
- KEYTRUDA (Biological) $53.37
- SIR-Spheres Microspheres (Device) $43.57
- AFINITOR (Drug) $40.00
- FARYDAK (Drug) $27.49
- Zevalin (Drug) $27.09
- Stivarga (Drug) $23.66
- JADENU (Drug) $23.58
- Flexitouch Plus (Device) $22.94
- XOSPATA (Drug) $20.28
- GAZYVA (Biological) $20.07
- POTELIGEO (Drug) $17.37
- ELIQUIS (Drug) $16.89
- VOTRIENT (Drug) $16.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Bay Shore
John Loscalzo, Md, MD
Hematology & Oncology — Payments: $13,112
Hematology & Oncology $13,112
Kathy Deng, M.d, M.D
Hematology & Oncology — Payments: $13,054
Hematology & Oncology $13,054
Dr. Mary Puccio, Md, MD
Hematology & Oncology — Payments: $2,959
Hematology & Oncology $2,959
Dr. Jia Llon Yee, M.d, M.D
Hematology & Oncology — Payments: $1,598
Hematology & Oncology $1,598
Ashley D'silva, M.d, M.D
Hematology & Oncology — Payments: $638.87
Hematology & Oncology $638.87
Dr. Kenneth Gold, Md, MD
Hematology & Oncology — Payments: $240.84
Hematology & Oncology $240.84